Therapy Areas: Respiratory
Polarean expands Ascend Imaging partnership to boost US market reach
6 October 2025 - Medical imaging technology company Polarean Imaging plc (AIM: POLX) announced on Monday that it has expanded its commercial agreement with Ascend Imaging LLC, extending coverage of it...
Jazz Pharmaceuticals' Zepzelca (lurbinectedin) and atezolizumab (Tecentriq) combination approved by FDA in ES-SCLC
3 October 2025 - Ireland-based pharmaceutical company Jazz Pharmaceuticals plc (Nasdaq:JAZZ) announced on Thursday that the US Food and Drug Administration (FDA) has granted approval for Zepzelca (lur...
Merck's WINREVAIR reduces clinical worsening by 76% in early PAH patients
30 September 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Tuesday announced positive Phase 3 results from the HYPERION trial evaluating WI...
Genmab to acquire Merus in USD8bn all-cash deal
30 September 2025 - Danish biotechnology company Genmab A/S (CPH: GMAB) has entered into a definitive agreement to acquire EQT Life Sciences portfolio company Merus N.V. (NASDAQ: MRUS) in an all-cash ...
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
29 September 2025 - Medical imaging technology company Polarean Imaging plc (AIM: POLX), a leader in functional lung MRI, announced on Monday that it has entered into a new supply agreement with Unive...
PureTech reports positive extension data for Deupirfenidone in IPF
29 September 2025 - Biotherapeutics company PureTech Health plc (Nasdaq: PRTC) (LSE: PRTC) said on Monday that it has presented new results from the open-label extension of its Phase 2b ELEVATE IPF tr...